Canada· CA-DIN-02335204

PREVNAR 13

A pneumokokken, gereinigtes polysaccharid-antigen, konjugiert product containing pneumococcal polysaccharide serotype 6a + pneumococcal polysaccharide serotype 23f + pneumococcal polysaccharide serotype 18c + pneumococcal polysaccharide serotype 19f, registered in Canada by PFIZER CANADA ULC. The same ATC class is registered in 11 of our 19 countries.

ATC J07AL02

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedPREVNAR 13ATCJ07AL02REGISTER NO.CA-DIN-02335204PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Pneumokokken, gereinigtes polysaccharid-antigen, konjugiert is registered in 11 of 19 countries.

Countries holding a registration under ATC J07AL02 (pneumokokken, gereinigtes polysaccharid-antigen, konjugiert), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose

Pneumokokken, gereinigtes polysaccharid-antigen, konjugiert · ATC J07AL02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A + PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F + PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C + PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F
Manufacturer
PFIZER CANADA ULC
Country
Canada (CA)
ATC code
J07AL02
ATC class
Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a8a2008e-a7d6-41aa-8581-0d6e0d6e564a
GET /v1/drugs/a8a2008e-a7d6-41aa-8581-0d6e0d6e564a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02335204",
  "form": "SUSPENSION",
  "class": "Human",
  "routes": [
    "INTRAMUSCULAR"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "J07AL02",
  "schedule": [
    "Schedule D"
  ],
  "drug_code": "82074",
  "strengths": [
    "2.2 MCG",
    "4.4 MCG",
    "34 MCG"
  ],
  "ahfs_class": null,
  "substances": [
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5",
    "CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4",
    "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1"
  ],
  "product_categorization": null
}

See everything about pneumokokken, gereinigtes polysaccharid-antigen, konjugiert.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.